Improved survival after liver transplantation in patients with hepatopulmonary syndrome

American Journal of Transplantation

Volumn 10, Issue 2, 2010, Pages 354-363

  Gupta, S ^a,b,c   Castel, H ^d,e   Rao, R V ^a   Picard, M ^d,e   Lilly, L ^f   Faughnan, M E ^a,b,c   Pomier Layrargues, G ^d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Hepatopulmonary syndrome; Liver transplantation; Living donor; Posttransplant complications; Transplantation

Indexed keywords

MACROSALB I 131; RAPAMYCIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FOLLOW UP; GAS EXCHANGE; GRAFT SURVIVAL; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; OUTCOME ASSESSMENT; OXYGENATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURGICAL MORTALITY; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; OXYGEN; OXYGEN INHALATION THERAPY; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

EID: 75149144775     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02822.x     Document Type: Article

References (34)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders Scientific Committee. [Review] [281 refs]. Eur Respir J 2004 24 : 861 880.
2. Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol 2007 5 : 749 754.
3. Lima BL, Franca AV, Pazin-Filho A et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004 79 : 42 48.
4. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003 125 : 1042 1052.
5. Schiffer E, Majno P, Mentha G et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: A prospective study in 90 patients. Am J Transplant 2006 6 : 1430 1437.
6. Fallon MB, Krowka MJ, Brown RS et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 2008 135 : 1168 1175.
7. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 2005 41 : 1122 1129.
8. Krowka MJ, Mandell MS, Ramsay MA et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transplant 2004 10 : 174 182.
9. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003 37 : 192 197.
10. Taille C, Cadranel J, Bellocq A et al. Liver transplantation for hepatopulmonary syndrome: A ten-year experience in Paris, France. Transplantation 2003 75 : 1482 1489 discussion 1446-1487.
11. Krowka MJ, Porayko MK, Plevak DJ et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: Case reports and literature review. Mayo Clin Proc 1997 72 : 44 53.
12. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995 109 : 1283 1288.
13. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome - a liver-induced lung vascular disorder. [Review] [50 refs]. N Engl J Med 2008 358 : 2378 2387.
14. American Thoracic Society. ATS Documents: Statements, Guidelines and Reports. http://www.thoracic.org/sections/publications/statements/index.html. Accessed April 8, 2009.
15. Health Resources and Services Administration HSB, Division of Transplantation. CHAPTER V: Liver and Intestine Transplantation in the United States, 1997-2006. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville. 2007. http://www.ustransplant.org/annual- reports/current/Chapter-V-AR-CD.htm?cp=6#18. Accessed April 8, 2009.
16. Health Resources and Services Administration HSB, Division of Transplantation. Scientific Registry of Transplant Recipients. In: USTransplant, ed. 2009. http://www.ustransplant.org/csr/current/modtabs.aspx?organ=LIC&c= P&y=1&format=HTML. Accessed April 9, 2009.
17. Walia A, Schumann R. The evolution of liver transplantation practices. [Review] [57 refs]. Curr Opin Organ Transplant 2008 13 : 275 279.
18. Ozier Y, Klinck JR. Anesthetic management of hepatic transplantation. [Review] [100 refs]. Curr Opin Anaesthesiol 2008 21 : 391 400.
19. Kahn JM, Fuchs BD. Identifying and implementing quality improvement measures in the intensive care unit. [Review] [47 refs]. Curr Opin Crit Care 2007 13 : 709 713.
20. Rimensberger PC. ICU cornerstone: High frequency ventilation is here to stay. Crit Care 2003 7 : 342 344.
21. Egawa H, Kasahara M, Inomata Y et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999 67 : 712 717.
22. Greif R, Akca O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group [see comment]. N Engl J Med 2000 342 : 161 167. (Pubitemid 30051647)
23. Gupta S, Faughnan ME, Prud'homme GJ, Hwang DM, Munoz DG, Kopplin P. Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome. Can Respir J 2008 15 : 124 126.
24. Durand P, Baujard C, Grosse AL et al. Reversal of hypoxemia by inhaled nitric oxide in children with severe hepatopulmonary syndrome, type 1, during and after liver transplantation. Transplantation 1998 65 : 437 439.
25. Alexander J, Greenough A, Baker A, Rela M, Heaton N, Potter D. Nitric oxide treatment of severe hypoxemia after liver transplantation in hepatopulmonary syndrome: Case report. Liver Transplant Surg 1997 3 : 54 55.
26. Meyers C, Low L, Kaufman L, Druger G, Wong LL. Trendelenburg positioning and continuous lateral rotation improve oxygenation in hepatopulmonary syndrome after liver transplantation. Liver Transplant Surg 1998 4 : 510 512.
27. Taniai N, Onda M, Tajiri T et al. Reversal of hypoxemia by inhaled nitric oxide in a child with hepatopulmonary syndrome after living-related liver transplantation. Transplant Proc 2002 34 : 2791 2792.
28. Carey EJ, Douglas DD, Balan V et al. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single-center experience. Liver Transplant 2004 10 : 529 533.
29. Nagral A, Nabi F, Humar A et al. Reversal of severe hepato-pulmonary syndrome in congenital hepatic fibrosis after living-related liver transplantation. Indian J Gastroenterol 2007 26 : 88 89.
30. Krowka MJ, Wiseman GA, Burnett OL et al. Hepatopulmonary syndrome: A prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest 2000 118 : 615 624.
31. Kaymakoglu S, Kahraman T, Kudat H et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Digest Dis Sc 2003 48 : 556 560.
32. Takatsuki M, Eguchi S, Kawashita Y, Kanematsu T. Biliary complications in recipients of living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2006 13 : 497 501.
33. Pascher A, Neuhaus P. Biliary complications after deceased-donor orthotopic liver transplantation. J Hepatobiliary Pancreat Surg 2006 13 : 487 496.
34. Hebert PC, Wells G, Tweeddale M et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997 155 : 1618 1623.